Nasal Drug Delivery Systems Dynamics - 2021 to 2031
The Nasal Drug Delivery Systems Market is expected to register a CAGR of 7.9% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by By Containers (Pressurized Containers and Non-Pressurized Containers), Type (Nasal Drops, Nasal Sprays, Nasal Gels and Others), Application (Nasal Congestion, Allergy, Vaccination, Rhinitis and Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Nasal Drug Delivery Systems Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Nasal Drug Delivery Systems Market Segmentation
Containers- Pressurized Containers and Non-Pressurized Containers
- Nasal Drops
- Nasal Sprays
- Nasal Gels and Others
- Nasal Congestion
- Allergy
- Vaccination
- Rhinitis and Others
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Nasal Drug Delivery Systems Market Growth Drivers- Increasing Prevalence of Respiratory Diseases: High prevalence of respiratory diseases including asthma, COPD, allergic rhinitis, and sinusitis pushes a big burden on the rise in incidence of the disease and thereby creates a sharp increase in the demand for effective nasal drug delivery systems to target appropriate therapy.
- Benefits of Nasal Administration: With the nasal drug delivery route, absorption occurs quickly and there is direct delivery of the drug to the systemic circulation or the local site, so therapeutic effects are seen more quickly, with better patient outcomes. Since acute conditions and chronic diseases are prevalent and require instant relief, it is a significant method of drug delivery.
- Increased Prevalence of Non-Invasive Drug Delivery Techniques: Nasal delivery is less invasive, and therefore, patients prefer it over injections. This can improve patient compliance, especially with patients who fear needles. Nasal delivery is perceived to be more convenient and less painful than invasively delivered drugs, hence improving the compliance to the medication regimen.
- Technological Advancement: Formulation technologies related to advancements in nanoparticles, microneedles, and other advanced drug delivery systems improve the efficiency and effectiveness of nasal drug delivery. The burgeoning trend of smart delivery systems, including smart nasal sprays and controlled release systems with sensor-integrated and technology-enabled triggered release of drugs, shall support market growth further.
- Personalized Medicine: The nasal delivery system include the trend toward personalized medicine, which is the development of tailored drug delivery for every individual and patient. The continuously merging advancement between sectors-healthcare and biotechnology-is a form of interaction that will likely spur changes in personalized medicine and nasal drug delivery.
- Increased R&D: The pharmaceutical industry is increasing investment in R&D on innovative nasal formulations and devices. Bioavailability levels are continually improved, and targeted conditions for respiration are being treated. In this regard, a lot of new products are finding their way into the market.
- Rising Demand for Self-Administration: The trend to administer the therapies on self-help basis gives a much-needed impetus to the nasal drug delivery market, particularly for chronic conditions that require long-term treatment. Again, it will take the form of OTC nasal sprays and devices.
- Regulatory Support and Approvals: The regulators have developed a friendly approach towards the new formulations of drugs and delivery systems. It results in accelerating timelines toward approvals as well as bringing new nasal drugs into the market. This increased regulatory support also has a good impact on the approval environment for nasal drug formulations.
- Increasing Popularity of Biologics and Vaccines: Nasal delivery is witnessing increased growth development in biologic drugs and vaccines. Nasal delivery improves patient compliance, whereas the invasive delivery route for vaccines is eliminated. In the case of biologics, such as monoclonal antibodies and peptides, these have been developed to target specific diseases, including cancer and autoimmune diseases. Administration of these drugs by nasal delivery improves the acceptability of these drugs among the patients and increases patient compliance.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Nasal Drug Delivery Systems Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Nasal Drug Delivery Systems Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Nasal Spray segment accounts for highest revenue in type sgement in 2023
Asia Pacific region dominated the nasal drug delivery systems market in 2023
The Nasal Drug Delivery Systems is estimated to witness a CAGR of 7.9% from 2023 to 2031
The major factors driving the nasal drug delivery systems market are:
1.Increasing Prevalence of Respiratory Diseases
2. Benefits of Nasal Administration
3. Increased Prevalence of Non-Invasive Drug Delivery Techniques
North America region dominated the nasal drug delivery systems market in 2023
3M, OptiNose US, Inc, AptarGroup, Inc, BD, GlaxoSmithKline plc, AstraZeneca, Merck & Co., Inc, Pfizer Inc, B.F. Ascher & Company, Inc, and Neurelis, Inc. are are some of the major market players operating in the market
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Nasal Drug Delivery Systems Market- By Containers
1.3.2. Nasal Drug Delivery Systems Market- By Type
1.3.3. Nasal Drug Delivery Systems Market- By Application
1.3.4. Nasal Drug Delivery Systems Market- By Region
1.3.4.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NONINVASIVE PRENATAL DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis
5. NASAL DRUG DELIVERY SYSTEMS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NASAL DRUG DELIVERY SYSTEMS MARKET- GLOBAL ANALYSIS
6.1. NASAL DRUG DELIVERY SYSTEMS MARKET - GLOBAL MARKET OVERVIEW
6.2. NASAL DRUG DELIVERY SYSTEMS MARKET - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. NASAL DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2028 - CONTAINERS
7.1. OVERVIEW
7.2. CONTAINERS MARKET FORECASTS AND ANALYSIS
7.3. PRESSURIZED CONTAINERS MARKET
7.3.1. Overview
7.3.2. Pressurized Containers Market Forecast and Analysis (US$ Mn)
7.4. UN-PRESSURIZED CONATINERS MARKET
7.4.1. Overview
7.4.2. Un-Pressurized Containers Forecast and Analysis (US$ Mn)
8. NASAL DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. NASAL DROPS MARKET
8.3.1. Overview
8.3.2. Nasal Drops Market Forecast and Analysis (US$ Mn)
8.4. NASAL SPRAYS MARKET
8.4.1. Overview
8.4.2. Nasal Sprays Market Forecast and Analysis (US$ Mn)
8.5. NASAL GELS MARKET
8.5.1. Overview
8.5.2. Nasal Gels Market Forecast and Analysis (US$ Mn)
8.6. OTHERS MARKET
8.6.1. Overview
8.6.2. Others Modelling Market Forecast and Analysis (US$ Mn)
9. NASAL DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. NASAL CONGESTION MARKET
9.3.1. Overview
9.3.2. Nasal Congestion Market Forecast and Analysis (US$ Mn)
9.4. ALLERGRY MARKET
9.4.1. Overview
9.4.2. Allergy Market Forecast and Analysis (US$ Mn)
9.5. VACCINATION MARKET
9.5.1. Overview
9.5.2. Vaccination Market Forecast and Analysis (US$ Mn)
9.6. RHINITIS MARKET
9.6.1. Overview
9.6.2. Rhinitis Market Forecast and Analysis (US$ Mn)
9.7. OTHERS MARKET
9.7.1. Overview
9.7.2. Others Modelling Market Forecast and Analysis (US$ Mn)
?
10. NASAL DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA NASAL DRUG DELIVERY SYSTEMS MARKET
10.1.1. North America Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.1.3. North America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.1.4. North America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.1.5. North America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.1.6.2. US Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.3. US Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.1.7.2. Canada Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.3. Canada Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.1.8.2. Mexico Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.3. Mexico Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2. EUROPE NASAL DRUG DELIVERY SYSTEMS MARKET
10.2.1. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.3. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.4. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.5. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.6.2. UK Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.3. UK Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.7.2. Germany Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.3. Germany Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.8.2. France Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.3. France Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.9. Italy Market Overview
10.2.9.1. Italy Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.9.2. Italy Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.9.3. Italy Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.10. Spain Market Overview
10.2.10.1. Spain Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.10.2. Spain Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.10.3. Spain Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3. ASIA PACIFIC NASAL DRUG DELIVERY SYSTEMS MARKET
10.3.1. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.3. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.4. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.5. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.3.6. Japan Market Overview
10.3.6.1. Japan Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.6.2. Japan Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.3. Japan Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.7. India Market Overview
10.3.7.1. India Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.7.2. India Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.3. India Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.8. China Market Overview
10.3.8.1. China Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.8.2. China Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.3. China Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.9. South Korea Market Overview
10.3.9.1. South Korea Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.9.2. South Korea Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.9.3. South Korea Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.10. Australia Market Overview
10.3.10.1. Australia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.10.2. Australia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.10.3. Australia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.4. MIDDLE EAST & AFRICA (MEA) NASAL DRUG DELIVERY SYSTEMS MARKET
10.4.1. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.4.3. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.4.4. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.4.5. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.4.6. South Africa Market Overview
10.4.6.1. South Africa Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.4.6.2. South Africa Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.3. South Africa Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.4.7.2. Saudi Arabia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.3. Saudi Arabia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.4.8. UAE Market Overview
10.4.8.1. UAE Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.4.8.2. UAE Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.3. UAE Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA NASAL DRUG DELIVERY SYSTEMS MARKET
10.5.1. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.5.3. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.5.4. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.5.5. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.5.6.2. Brazil Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.3. Brazil Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.5.7. Argentina Market Overview
10.5.7.1. Argentina Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.5.7.2. Argentina Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.5.7.3. Argentina Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions
12. NASAL DRUG DELIVERY SYSTEMS MARKET, KEY COMPANY PROFILES
12.1. 3M
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product/Service Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. OPTINOSE US, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product/Service Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. APTARGROUP, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product/Service Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product/Service Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLASOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product/Service Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product/Service Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK & CO., INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product/Service Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product/Service Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. B.F. ASCHER & COMPANY, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product/Service Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NEURELIS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product/Service Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments
?
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
NOTE:
• This ToC is tentative in nature and is subject to further refinement during the course of the research study
• The list of company profiles included in this ToC is tentative. Profiles of specific players, if required, shall be added to the report upon request.
• Financials can be provided to the extent of availability in the public domain.
The List of Companies
1. 3M
2. OptiNose US, Inc.
3. AptarGroup, Inc.
4. BD
5. GlaxoSmithKline plc.
6. AstraZeneca
7. Merck & Co., Inc.
8. Pfizer Inc
9. B.F. Ascher & Company, Inc.
10. Neurelis, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For